Mark Wallace - Escalon Medical COO Officer
| ESMCDelisted Stock | USD 0.06 0.00 0.00% |
COO
Mr. Mark G. Wallace serves as Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer of Escalon Medical Corporationration since January 1, 2008 since 2017.
| Age | 53 |
| Tenure | 7 years |
| Phone | 610 688 6830 |
| Web | https://www.escalonmedical.com |
Mark Wallace Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Wallace against Escalon Medical otc stock is an integral part of due diligence when investing in Escalon Medical. Mark Wallace insider activity provides valuable insight into whether Escalon Medical is net buyers or sellers over its current business cycle. Note, Escalon Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Escalon Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Wallace over a year ago Payment of 447 shares by Mark Wallace of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over a year ago Acquisition by Mark Wallace of 11499 shares of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over a year ago Acquisition by Mark Wallace of 11499 shares of Keysight Technologies subject to Rule 16b-3 | ||
Mark Wallace over a year ago Acquisition by Mark Wallace of 24281 shares of Uniti subject to Rule 16b-3 |
Escalon Medical Management Efficiency
The company has return on total asset (ROA) of (0.0724) % which means that it has lost $0.0724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4225) %, meaning that it created substantial loss on money invested by shareholders. Escalon Medical's management efficiency ratios could be used to measure how well Escalon Medical manages its routine affairs as well as how well it operates its assets and liabilities.Escalon Medical Corp currently holds 153.43 K in liabilities with Debt to Equity (D/E) ratio of 0.82, which is about average as compared to similar companies. Escalon Medical Corp has a current ratio of 1.36, which is within standard range for the sector. Debt can assist Escalon Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Escalon Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Escalon Medical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Escalon to invest in growth at high rates of return. When we think about Escalon Medical's use of debt, we should always consider it together with cash and equity.
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. Escalon Medical Corp. was incorporated in 1987 and is based in Wayne, Pennsylvania. Escalon Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 41 people. Escalon Medical Corp [ESMC] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Escalon Medical is listed under Medical Equipment category by Fama And French industry classification. Management Performance
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 |
Escalon Medical Corp Leadership Team
Elected by the shareholders, the Escalon Medical's board of directors comprises two types of representatives: Escalon Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Escalon. The board's role is to monitor Escalon Medical's management team and ensure that shareholders' interests are well served. Escalon Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Escalon Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard DePiano, CEO and President General Counsel and Director | ||
| Mark Wallace, COO Officer |
Escalon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Escalon Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 2.07 M | ||||
| Shares Outstanding | 7.42 M | ||||
| Shares Owned By Insiders | 1.90 % | ||||
| Number Of Shares Shorted | 2.01 K | ||||
| Price To Earning | 4.50 X | ||||
| Price To Book | 1.12 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Escalon OTC Stock
If you are still planning to invest in Escalon Medical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Escalon Medical's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |